Federal Register / Vol. 89, No. 40 / Wednesday, February 28, 2024 / Notices 14669 

92. Robert Hightower, Crystal, Minnesota, 

Court of Federal Claims No: 24–0137V 

93. Handson Bota, Boston, Massachusetts, 

Court of Federal Claims No: 24–0138V 

94. Jason Manus, Teterboro, New Jersey, 

Court of Federal Claims No: 24–0140V 

95. Alice Keenan, Holland, Pennsylvania, 

Court of Federal Claims No: 24–0141V 

96. Karina A. Then, Providence, Rhode 

Island, Court of Federal Claims No: 24– 

0142V 

97. Valerie Parker, Columbus, Ohio, Court of 

Federal Claims No: 24–0143V 

98. Kristen McLaughlin, Universal City, 

California, Court of Federal Claims No: 

24–0147V 

99. Jaquel E. Simmons, Waupun, Wisconsin, 

Court of Federal Claims No: 24–0148V 

100. Melissa French, Covington, Kentucky, 

Court of Federal Claims No: 24–0149V 

101. Lisa Regina Vandenberg, Elmwood Park, 

New Jersey, Court of Federal Claims No: 

24–0150V 

102. Briana N. Gonzalez on behalf of L. G., 

Deceased, Aventura, Florida, Court of 

Federal Claims No: 24–0153V 

103. Andrea Flynn, Chapel Hill, North 

Carolina, Court of Federal Claims No: 

24–0154V 

104. Stepfanie Allstead, Elk Grove, 

California, Court of Federal Claims No: 

24–0156V 

105. Debbie Loyim, New York, New York, 

Court of Federal Claims No: 24–0158V 

106. Christina Moser, Woodbridge, Virginia, 

Court of Federal Claims No: 24–0159V 

107. Destiny Ramos on behalf of Y. G. G., 

Deceased, New York, New York, Court of 

Federal Claims No: 24–0161V 

108. Jamie Mize on behalf of R. P., Deceased, 

Oakland, California, Court of Federal 

Claims No: 24–0163V 

[FR Doc. 2024–04140 Filed 2–27–24; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Stakeholder Listening Session on 

Public Health Emergencies 

Preparedness and Response 

Negotiations 

AGENCY: Office of Global Affairs, 

Department of Health and Human 

Services. 

ACTION: Notice of public listening 

session; request for comments. 

DATES: The listening session will be 

held Thursday, April 11, 2024, from 

10:00 a.m. to 12:00 p.m. Eastern 

Daylight Time. This session is open to 

the public but requires RSVP to 

oga.rsvp@hhs.gov by Friday, April 5, 

2024. See RSVP section in 

SUPPLEMENTARY INFORMATION for details. 

ADDRESSES: The session will be held 

virtually, with online and dial-in 

information shared with registered 

participants. 

SUPPLEMENTARY INFORMATION: 

Purpose: The U.S. Department of 

Health and Human Services (HHS), with 

support from relevant health-related 

U.S. Government offices, is charged 

with leading U.S. participation in the 

Working Group on the Amendments to 

the International Health Regulations 

(2005) (WGIHR) and with co-leading the 

U.S. delegation to the Intergovernmental 

Negotiating Body to draft and negotiate 

a WHO convention, agreement or other 

international instrument on pandemic 

prevention, preparedness and response 

(INB). HHS will convene an informal 

Stakeholder Listening Session. 

The Stakeholder Listening Session is 

designed to seek input from 

stakeholders and subject matter experts 

to help inform U.S. Government 

engagement with the WGIHR and INB. 

Background, WGIHR: The World 

Health Assembly originally adopted the 

International Health Regulations (IHR) 

in 1969. The regulations were amended 

multiple times, most recently in 2005. 

The purpose of IHR is to prevent, 

protect against, control, and provide 

public health response to the 

international spread of disease. 

Member States of the World Health 

Organization (WHO) agreed in 2022 to 

embark on a process to amend the 

current IHR. The process builds on 

lessons learned from the various review 

panels that examined the functioning of 

the IHR and the global health security 

architecture during the COVID–19 

pandemic. The Working Group on the 

Amendments to the IHR (WGIHR) is 

considering more than 300 proposed 

amendments to 33 of the 66 articles of 

the IHR and 5 of its 9 annexes, plus 6 

new articles and 2 new annexes. More 

information on the WGIHR can be found 

here: https://www.who.int/teams/ihr/ 

working-group-on-amendments-to-theinternational-health-regulations- 

%282005%29. 

The WGIHR currently intends to 

submit its outcome to the Seventyseventh World Health Assembly in May 

2024. 

Background, INB: In December 2021, 

WHO Member States decided at a 

Special Session of the World Health 

Assembly to establish an 

intergovernmental negotiating body 

(INB), representing all regions of the 

world, to draft and negotiate a WHO 

convention, agreement, or other 

international instrument on pandemic 

prevention, preparedness, and response. 

More information about the INB process 

can be found here: https://inb.who.int/ 

home/inb-process. 

The INB currently intends to submit 

its outcome to the Seventy-seventh 

World Health Assembly in May 2024. 

The United States has expressed 

support for the development of an 

international instrument to protect the 

world from pandemic health threats 

now and in the future, and in a more 

rapid and equitable manner. 

The United States is seeking the 

following key outcomes in the 

negotiations: 

• Enhance the capacity of countries 

around the world to prevent, prepare 

for, and respond to pandemic 

emergencies and provide clear, credible, 

consistent information to their citizens. 

• Ensure that all countries share data 

and laboratory samples from emerging 

outbreaks quickly, safely, and 

transparently to facilitate response 

efforts and inform public health 

decision making regarding effective 

disease control measures, including the 

rapid creation of safe and effective 

vaccines, diagnostic tests, and 

treatments. 

• Support more equitable and timely 

access to, and delivery of, vaccines, 

diagnostic tests, treatments, and other 

mitigation measures to quickly contain 

outbreaks, reduce illness and death, and 

minimize impacts on the economic and 

national security of people around the 

world. 

Matters to be Discussed: The listening 

session will discuss the outcome 

products of the WGIHR and INB to be 

submitted to the Seventy-seventh World 

Health Assembly in May. Topics will 

include those amendments currently 

under consideration by the WGIHR; 

areas of consideration included in the 

Pandemic Accord; and key proposals 

that highlight the intersection between 

the IHR and the Pandemic Accord. An 

Article-by-Article Compilation of 

Proposed Amendments to the 

International Health Regulations (2005) 

can be found here: https://apps.who.int/ 

gb/wgihr/pdf_files/wgihr1/WGIHR_

Compilation-en.pdf. More information 

on the Pandemic Accord can be found 

here: https://apps.who.int/gb/inb/ 

index.html. 

Participation is welcome from 

stakeholder communities, including: 

• Public health and advocacy groups 

• State, local, and Tribal groups 

• Private industry 

• Minority health organizations 

• Academic and scientific 

organizations, etc. 

RSVP: Persons seeking to participate 

in the listening session must register by 

Friday, April 5, 2024. 

Registrants must include their full 

name, email address, and organization, 

if any, and indicate whether they are 

registering as a listen-only attendee or 

as a speaker participant to oga.rsvp@

hhs.gov. 


ddrumheller on DSK120RN23PROD with NOTICES1
14670 Federal Register / Vol. 89, No. 40 / Wednesday, February 28, 2024 / Notices 

Requests to participate as a speaker 

must include all of the following 

information: 

1. The name and email address of the 

person desiring to participate 

2. The organization(s) that person 

represents, if any 

3. The document(s) and primary 

article(s) of interest, listed in order of 

the speaker’s priorities 

Other Information: Written comments 

should be emailed to oga.rsvp@hhs.gov 

with the subject line ‘‘Written Comment 

Re: Stakeholder Listening Session on 

public health emergencies preparedness 

and response negotiations’’ by 

Wednesday, April 17, 2024. 

We look forward to your comments on 

these matters. 

Dated: February 22, 2024. 

Susan Kim, 

Principal Deputy Assistant Secretary. 

[FR Doc. 2024–04080 Filed 2–27–24; 8:45 am] 

BILLING CODE 4150–38–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Government-Owned Inventions; 

Availability for Licensing 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The invention listed below is 

owned by an agency of the U.S. 

Government and is available for 

licensing to achieve expeditious 

commercialization of results of 

federally-funded research and 

development. Foreign patent 

applications are filed on selected 

inventions to extend market coverage 

for companies and may also be available 

for licensing. 

FOR FURTHER INFORMATION CONTACT: 

Wade Green at (301) 761–7505 or 

greenww@nih.gov. Licensing 

information may be obtained by 

communicating with the Technology 

Transfer and Intellectual Property 

Office, National Institute of Allergy and 

Infectious Diseases, 5601 Fishers Lane, 

Rockville, MD 20852: tel. 301–496– 

2644. A signed Confidential Disclosure 

Agreement will be required to receive 

copies of unpublished information 

related to the invention. 

SUPPLEMENTARY INFORMATION: 

Technology description follows: 

An Innovative Adapter for Expedited 

and Automated Thawing of viably 

Frozen Cells. 

Description of Technology 

This technology is a device and 

system for expediting the thawing 

frozen specimens (e.g., cryopreserved 

cells) contained in cryo-vials, offering a 

breakthrough solution for researchers 

seeking efficiency and precision in their 

workflows. The device is equipped with 

a small elongated tubular adaptor that 

suspends a cryo-vial of frozen cells over 

a centrifuge tube containing culture 

medium in an inverted position. With a 

focus on speed, efficiency and 

automation, the adaptor dramatically 

expedites the process of recovering 

viable cells from frozen specimens. It 

reduces per-sample labor time for 

thawing from several minutes to a few 

seconds, enabling a single technician to 

simultaneously thaw multiple vials 

within the capacity of centrifuges. The 

cells, once thawed, are diluted instantly 

into growth medium contained in the 

centrifuge tubes and spend essentially 

no time in liquid cryopreservative. 

The automated mechanism ensures a 

precise and controlled thawing 

environment maintaining optimal 

temperature conditions throughout the 

thawing process. 

Potential Commercial Applications: 

• This device can be used in sample 

preparation and cell culturing. 

• Applicable for research materials, 

medical and non-medical devices and 

consumer products. 

Competitive Advantages: 

• Provides a faster process of 

recovering viable cells from frozen 

specimens. 

• Eliminates multi-step processes. 

• High throughput system with 

reduced variability. 

• Constant environment control. 

Development Stage: 

• Prototype 

Inventors: Dr. Mario Roederer, Dr. 

Pratip Chattopadhyay and Margaret 

Beddall, all of NIAID. 

Publications: n/a. 

Intellectual Property: HHS Reference 

No. E–080–2015–0–EIR–00 U.S. Patent 

Application No. 14/661,449, filed on 

March 18, 2015; Published Patent 

Application US20160274004A1 on 

September 22, 2016; U.S. Patent 

9,663,812 issued May 30, 2017. 

Licensing Contact: To license this 

technology, please contact Wade Green 

at (301) 761–7505 or greenww@nih.gov. 

and reference E–080–2015. 

Collaborative Research Opportunity: 

The National Institute of Allergy and 

Infectious Diseases is seeking statements 

of capability or interest from parties 

interested in collaborative research to 

further develop, evaluate, or 

commercialize this technology. For 

collaboration opportunities, please 

contact Wade Green at (301) 761–7505 

or greenww@nih.gov. 

Dated: February 7, 2024. 

Surekha Vathyam, 

Deputy Director, Technology Transfer and 

Intellectual Property Office, National Institute 

of Allergy and Infectious Diseases. 

[FR Doc. 2024–04060 Filed 2–27–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Environmental 

Health Sciences; Notice of Closed 

Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Environmental Health Sciences Special 

Emphasis Panel; Career Development in K 

Applications. 

Date: March 20–21, 2024. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Environmental 

Health Science, 530 Davis Drive, Keystone 

Building, Durham, NC 27713 (Virtual 

Meeting). 

Contact Person: Beverly W. Duncan, Ph.D., 

Scientific Review Officer, Division of 

Extramural Research and Training, National 

Institute of Environmental Health Science, 

Keystone Building, 530 Davis Drive, Room 

3130, Durham, NC 27713, (240) 353–6598, 

beverly.duncan@nih.gov. 

Name of Committee: National Institute of 

Environmental Health Sciences Special 

Emphasis Panel; Exposome Research 

Coordination to Accelerate Precision 

Environmental Health (PEH). 

Date: April 3, 2024. 

Time: 10:30 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Environmental 

Health Science, 530 Davis Drive, Keystone 

Building, Durham, NC 27713 (Virtual 

Meeting). 

Contact Person: Leroy Worth, Ph.D., 

Scientific Review Officer, Scientific Review 


ddrumheller on DSK120RN23PROD with NOTICES1